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ABSTRACT The highly virulent intracellular pathogen Francisella tularensis is a
Gram-negative bacterium that has a wide host range, including humans, and is the
causative agent of tularemia. To identify new therapeutic drug targets and vaccine
candidates and investigate the genetic basis of Francisella virulence in the Fischer
344 rat, we have constructed an F. tularensis Schu S4 transposon library. This library
consists of more than 300,000 unique transposon mutants and represents a trans-
poson insertion for every 6 bp of the genome. A transposon-directed insertion site
sequencing (TraDIS) approach was used to identify 453 genes essential for growth in
vitro. Many of these essential genes were mapped to key metabolic pathways, in-
cluding glycolysis/gluconeogenesis, peptidoglycan synthesis, fatty acid biosynthesis,
and the tricarboxylic acid (TCA) cycle. Additionally, 163 genes were identiﬁed as re-
quired for ﬁtness during colonization of the Fischer 344 rat spleen. This in vivo selec-
tion screen was validated through the generation of marked deletion mutants that
were individually assessed within a competitive index study against the wild-type F.
tularensis Schu S4 strain.
IMPORTANCE The intracellular bacterial pathogen Francisella tularensis causes a dis-
ease in humans characterized by the rapid onset of nonspeciﬁc symptoms such as
swollen lymph glands, fever, and headaches. F. tularensis is one of the most infec-
tious bacteria known and following pulmonary exposure can have a mortality rate
exceeding 50% if left untreated. The low infectious dose of this organism and con-
cerns surrounding its potential as a biological weapon have heightened the need for
effective and safe therapies. To expand the repertoire of targets for therapeutic de-
velopment, we initiated a genome-wide analysis. This study has identiﬁed genes that
are important for F. tularensis under in vitro and in vivo conditions, providing candi-
dates that can be evaluated for vaccine or antibacterial development.
KEYWORDS essential genes, Francisella, gene essentiality, TraDIS, transposon
insertion sequencing, genomics, virulence
Tularemia is a disease caused by Francisella tularensis, a highly infectious Gram-negative bacterium and member of the gamma subgroup of proteobacteria. F.
tularensis can infect a wide range of invertebrates, birds, and mammals, including
humans (1). Three subspecies have been identiﬁed: Francisella tularensis subsp. tular-
ensis occurs in North America, the less virulent Francisella tularensis subsp. holarctica is
found in North America and Europe, and Francisella tularensis subsp. mediasiatica is
found in central Asia. The route of infection inﬂuences the clinical presentation of the
disease, which can be classiﬁed as ulceroglandular, glandular, pneumonic, oculoglan-
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dular, oropharyngeal, or typhoidal (2). F. tularensis spreads systemically from the
regional lymph to organs, including the liver, lungs, and spleen. Symptoms of infection
can be nonspeciﬁc and include fever, malaise, chills, and headaches (3). Pneumonic
infection often produces the most severe disease presentation, and a fatality rate that
can exceed 50% without treatment (3), leading to concerns surrounding its potential for
biological warfare (4).
The infectious dose of F. tularensis is as low as 25 organisms (5). Therefore, it is
important that treatment regimens completely clear the bacterial infection upon
completion of the therapy. A number of antibiotics are effective for treatment of
tularemia, including streptomycin, gentamicin, tetracycline, chloramphenicol, doxycy-
cline, rifampin, and ciproﬂoxacin (6–8). The potential for relapse following treatment,
which can range from 6% to 21% (8–10), and the high toxicity of some antibiotics (11,
12) provide a need for improved therapies.
There is no vaccine licensed for F. tularensis infection. The live vaccine strain (LVS),
an attenuated F. tularensis subsp. holarctica isolate, has previously shown to partially
protect humans against aerosol challenge with the highly virulent F. tularensis subsp.
tularensis Schu S4 (13). The genomic changes that contribute to the attenuation of the
LVS are not fully understood and have in part prevented licensure. Additionally,
numerous live vaccine strain candidates have been constructed through deletion of
genes required for metabolism or virulence (14). However, potential reversion of single
deletion mutant strains back to wild-type virulence, although of low probability, has led
to the view that multiple genetic deletions should be considered (14). Consequently, as
the number of genetic changes increases, so does the potential to overattenuate the
candidate strain with potential loss of immunogenicity (15). Generating live vaccine
strains with multiple lesions therefore continues to pose signiﬁcant challenge.
A range of virulence factors utilized by F. tularensis to facilitate entry and survival in
a host are known. These virulence genes include, for example, the intracellular growth
locus (16), mglA and mglB (17), type IV pilus genes (18), lipopolysaccharide (LPS) genes
(19), and capsule genes (20). F. tularensis is able to evade the immune response and,
through inhibition of endosome-lysosome fusion, escape and replicate in the macro-
phage cystol. However, current understanding of F. tularensis virulence stems largely
from studies using murine models of infection and in vitro cell lines. The use of
surrogate strains that can be handled safely at lower levels of laboratory containment,
such as the LVS or Francisella novicida, has vastly accelerated developments within the
ﬁeld. Nevertheless, despite causing lethality in murine models, these strains are not
virulent in humans (F. novicida infection has been reported with near-drowning inci-
dents and immunocompromised individuals [21, 22]). Thus, studies with F. tularensis
Schu S4 and similar lethal strains are crucial to complement work with surrogate strains
and increase our understanding of the virulence of this pathogen in humans.
Transposon-based mutagenesis is an effective and increasingly utilized approach to
evaluate the impact of a gene on the viability or ﬁtness of bacteria through insertional
inactivation. Recent advances in high-throughput sequencing have facilitated tech-
niques such as insertion sequencing (INseq) (23), transposon-directed insertion site
sequencing (TraDIS) (24), transposon sequencing (Tn-seq) (25), high-throughput inser-
tion tracking by deep sequencing (HITS) (26), and barcode analysis by sequencing
(Bar-seq) (27), that enable the selective enrichment of transposon-genome junctions
from saturating transposon libraries. Analysis of transposon insertion frequency across
a genome can provide an assessment of all genes under speciﬁc conditions at high
resolution. The minimal set of genes required under nutritious conditions provides
important information regarding key biochemical processes within the organism.
However, the essentiality or ﬁtness contribution of a gene largely depends on the
context of the environment inhabited by the organism. Therefore, for the purpose of
therapeutic development, the identiﬁcation of genes that are required for ﬁtness of a
pathogen in a host can offer an alternative strategy for antibacterial or vaccine
development.
Here we describe the generation and analysis of an F. tularensis Schu S4 transposon
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library. We have used this library to carry out a global analysis of essential genes and
genes which contribute to spleen colonization within Fischer 344 rats. The data
generated provide a resource that can allow further investigations into the mechanisms
of Francisella virulence. Additionally, these data can facilitate the rational design of live
attenuated vaccine strains and novel antimicrobial targets for the prevention and
treatment of tularemia.
RESULTS
Construction and sequencing of a saturated F. tularensis Schu S4 transposon
library. An F. tularensis Schu S4 library was constructed using the pHimarH3 transposon
(28). Sequencing of transposon-genome junctions that had been selectively enriched
by PCR generated approximately 15 million reads for each replicate, of which 92% to
96% mapped to the F. tularensis Schu S4 genome (Table 1). The EMBOSS fuzznuc
application (29) was used to identify the existence of 414,318 potential Himar1 insertion
site recognition sequences (TA) on the forward and complement strands of the F.
tularensis Schu S4 genome. Therefore, a mean mutant library size of 323,702 would
indicate that 78% of Himar1 recognition sites in the F. tularensis library genome
contained transposon insertions.
Prediction of genes essential to F. tularensis Schu S4. The use of transposons to
identify genes that are required for growth under the test condition can enable
identiﬁcation of those genes that are unable to tolerate transposon insertions and are
likely to be essential for bacterial growth or survival. The Bio::Tradis pipeline (30, 31) was
used to analyze mapped reads and predict genes essential for F. tularensis Schu S4.
Following mapping of PCR-enriched transposon-genome junctions, the insertion count
per gene for each replicate was tallied and normalized for gene length (insertion
count/gene length) to calculate the insertion index. The insertion index for each was
compared across three biological replicates as a scatter plot (Fig. 1) to give a high
correlation coefﬁcient, 0.98. We determined that the TA count per gene was highly
correlated to gene length, with a Spearman r value of 0.97 and a 95% conﬁdence
interval of 0.96 to 0.97, thereby validating gene length a suitable normalizing factor for
insertion count in the F. tularensis genome.
To differentiate the essential from nonessential genes, the insertion index for each
gene was plotted by frequency (Fig. 2A). This revealed a bimodal distribution, and the
minimal value between the two modes was calculated. Analysis of F. tularensis Schu S4
TABLE 1 Summary of PCR-ampliﬁed transposon-genome junction sequencing reads mapped to the F. tularensis Schu S4 genome
following outgrowth of the library in MMH broth
Replicate No. of total reads No. of reads mapped % mappeda No. of UISsb Genome length/UIS
FT1 15,312,503 14,527,401 96.41 316,141 5.99
FT2 15,952,998 14,459,470 92.18 330,262 5.73
FT3 14,392,221 13,420,403 94.63 324,704 5.83
aDetermined from only the reads containing the transposon tag.
bUIS, unique insertion sites.
FIG 1 Pairwise comparison of gene insertion index values. Reproducibility of sequencing data was demonstrated by calculating the Spearman rank correlation
coefﬁcient between biological replicates.
Analysis of Gene Essentiality and Fitness of Schu S4 Journal of Bacteriology
April 2019 Volume 201 Issue 7 e00630-18 jb.asm.org 3
 o
n
 M
arch 29, 2019 by guest
http://jb.asm.org/
D
ow
nloaded from
 
transposon libraries in this study using the Bio::Tradis tools predicted genes with an
insertion index of 0.06 as essential. Gene essentiality was predicted for each of the
replicate libraries, with 453 genes present in all three (Fig. 2B). The raw data for each
replicate are available in Data Set S1 in the supplemental material and include the
essential gene sequences in fastA format. Genes identiﬁed as essential mapped to a
number of biochemical pathways using the Kyoto Encyclopedia of Genes and Genomes
(KEGG) resource (http://www.genome.jp/kegg/), including glycolysis/gluconeogenesis,
the tricarboxylic acid (TCA) cycle, fatty acid biosynthesis, and peptidoglycan synthesis
(Fig. S1).
Previously 396 candidate essential genes were identiﬁed in the related nonvirulent
species F. novicida U112 (32). F. tularensis Schu S4 genes predicted to be essential were
FIG 2 Prediction of gene essentiality from transposon libraries in F. tularensis Schu S4. (A) Insertion index
plotted against density demonstrates a bimodal distribution (representative, FT1 replicate). (B) Essenti-
ality analysis was performed on each replicate, identifying 453 genes that were present in all three. (C)
Comparison of essential genes from both F. novicida U112 (32) and F. tularensis Schu S4 (this study)
identiﬁed 339 predicted essential genes that are common to both species.
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used in a BLASTx search (expected cutoff, 1E10) against the F. novicida U112 data set
(32) utilizing the Database for Essential Genes (DEG) (http://tubic.tju.edu.cn/deg/) (33).
This identiﬁed 339 genes from F. tularensis Schu S4 that were also found to be essential
in F. novicida U112 (Fig. 2C). Additionally, a total of 57 genes were identiﬁed as essential
in F. novicida U112 but not essential in F. tularensis Schu S4.
The F. tularensis Schu S4 genes for which no homologue was predicted as essential
in F. novicida U112 (114 genes [Fig. 2C]) were used in a BLASTx analysis against the
remaining 45 bacterial essential gene data sets present in the DEG. This analysis
identiﬁed 25 putative F. tularensis Schu S4 essential genes that had no homologue. To
limit the possibility of falsely identifying novel essential genes, as a consequence of
either a small gene returning an expected value higher than the cutoff or genes with
areas of low complexity, the DEG BLASTx analysis was repeated on these 25 genes, this
time increasing the expected value cutoff to 1E05 and without using the low-
complexity ﬁlter. Nine genes returned hits, including FTT_0346 (rpmJ), FTT_0801c,
FTT_0839 (tolA), FTT_1030, FTT_1275 (mglA), FTT_1453c (wzx), FTT_1457c (wbtG),
FTT_1607 (minE), and FTT_1730c, and were therefore excluded from the novel essential
gene list.
BLASTx analysis of F. tularensis Schu S4 non-DEG homologues. In order to give
a suggestion of function for the 16 F. tularensis Schu S4 genes for which no DEG
homologues had been identiﬁed (Table 2), a similarity search was performed against
the NCBI nonredundant protein database, but excluding sequences from the Francisella
genus using BLASTx with an expected value threshold of 1E05. Many of the F.
tularensis essential genes consistently revealed homology to hypothetical genes found
in a wide range of environmental organisms often isolated from marine environments.
Three hypothetical genes, FTT_0913, FTT_1051c, and FTT_1113c, showed no signiﬁcant
homology to any sequences in the nonredundant database. However, it should be
noted that analysis of the TA site distribution across all genes within the F. tularensis
genome identiﬁed a single gene outlier (FTT_1051c) with a disproportionally lower
number of TA sites (10 sites) relative to its length. BLASTx and domain analyses and
structural analysis using the I-Tasser protein structure and function prediction tool (34)
were performed on the 16 genes of interest (Data Set S2). A number of conserved
domains were identiﬁed, including a redoxin domain identiﬁed in FTT_0557 (domain E
value, 1.20E22) that also showed structural homology (TM scores, 0.97 to 0.855) to
peroxiredoxin. A homologue for FTT_0696 was not identiﬁed in the DEG despite the
presence of an FtsL pfam (35) conserved domain (domain E value, 2.09E09). Although
14 studies in the DEG identiﬁed FtsL as essential, it has been noted that homologues
of FtsL often share domain structures that are similar but are not well conserved at the
amino acid level (36).
TABLE 2 Putative essential F. tularensis Schu S4 genes with no DEG homologues
Locus tag Gene name Start End Gene length Function
FTT_0057 FTT_0057 59627 60058 432 Hypothetical membrane protein
FTT_0070c ampG 70944 72209 1,266 Major facilitator superfamily transport protein
FTT_0181c FTT_0181c 197194 197730 537 Conserved membrane protein
FTT_0265 FTT_0265 278751 280550 1,800 ABC transporter, membrane protein
FTT_0557 FTT_0557 575197 575721 525 AhpC/TSA family protein
FTT_0696 FTT_0696 715529 715879 351 Hypothetical protein
FTT_0743 FTT_0743 766572 767387 816 Conserved hypothetical protein
FTT_0859c FTT_0859c 870754 871077 324 Hypothetical protein
FTT_0900 FTT_0900 909502 909873 372 Conserved hypothetical membrane protein
FTT_0913 FTT_0913 920784 921251 468 Hypothetical protein
FTT_0924 FTT_0924 935772 936170 399 Hypothetical membrane protein
FTT_1051c FTT_1051c 1061830 1061994 165 Hypothetical protein
FTT_1113c FTT_1113c 1123209 1123739 531 Hypothetical protein
FTT_1152 FTT_1152 1166334 1166717 384 Hypothetical protein
FTT_1489 FTT_1489 1542386 1543111 726 Hypothetical protein
FTT_1637c FTT_1637c 1702959 1703162 204 Hypothetical protein
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Identiﬁcation of genes required for optimal ﬁtness during infection. Extending
the essential gene analysis, we set out to determine the genes that are important within
a host environment. To identify genes important for ﬁtness of F. tularensis in the Fischer
344 rat, a TraDIS approach was again implemented. To avoid potential stochastic loss
of mutants from the output pool, the intravenous (i.v.) route was selected for challenge.
Fischer 344 rats were challenged i.v. at a dose of 7.8 106 CFU of the F. tularensis Schu
S4 himar1 transposon library. At this dose, by 4 h postchallenge the bacterial burden in
the spleen had reached a mean of 1.31 106 CFU/spleen (Fig. 3); this time point was
used as an indication of the number of bacteria present in the spleen prior to
replication. At 24 h postchallenge there was a mean of 7.32 108 CFU/spleen (Fig. 3),
representing a 559-fold increase in bacterial numbers.
Genomic DNA was isolated from the input pool and from bacteria isolated from rat
spleens at 24 h postchallenge. Transposon-genome junctions were selectively ampliﬁed
by PCR and sequenced, and ﬁtness analysis was performed using DESeq. To ensure
accuracy and reduce the number of genes falsely identiﬁed, only genes with an
arbitrary minimum value of 200 reads in the input were included in the analysis. A
2-fold reduction cutoff in read count between input and output was applied to
generate a list of 163 genes required for ﬁtness within the spleen. Those mutants not
present in the output were arbitrarily set a ﬁtness score of 15 (Table S4). Fifty percent
of genes conferring reduced ﬁtness in the rat spleen had previously been identiﬁed
using murine models of Francisella infection (Table S4). This includes genes identiﬁed
using F. tularensis subsp. holarctica and F. novicida strains. Of the 163 genes required for
ﬁtness in the rat spleen, 101 genes had not previously been identiﬁed as important for
virulence of F. tularensis subsp. tularensis and a further 19 genes had been identiﬁed
only through changes in gene expression. Additionally, 34 genes had not previously
been associated with virulence in any Francisella species or subspecies.
Validation of genes required for ﬁtness in Fischer 344 rats. To validate data from
this TraDIS study, genes were selected for deletion mutagenesis with an emphasis on
those not previously reported as involved in virulence (FTT_0232c ddg [acyltransferase],
FTT_0614c lnt [apolipoprotein N-acyltransferase], FTT_0970 [uncharacterized protein],
FTT_1220 [5-formyltetrahydrofolate cyclo-ligase], FTT_1567c zipA [cell division protein],
FTT_0687c hslU [ATP-dependent protease ATPase subunit], and FTT_1258 [outer mem-
brane efﬂux protein]) (Table S4). Additionally, a mutant that did not exhibit a ﬁtness
change (FTT_0715; P  0.934) was selected as a control. Initially, MMH broth was
inoculated with a 1:1 ratio of wild-type (WT) F. tularensis Schu S4 and each mutant. Schu
S4 Δlnt::Kanr and ΔFTT_1567::Kanr strains had signiﬁcantly reduced ﬁtness relative to
that of the WT (P  0.020 and P  0.035, respectively) (Fig. 4A).
The targeted marked deletion strains of F. tularensis Schu S4 were tested to assess
validity of the Fisher 344 rat ﬁtness data. Mutant strains were individually mixed in a 1:1
FIG 3 Colonization of Fischer 344 rat spleens with F. tularensis Schu S4. Two groups of rats were
challenged by the i.v. route with an F. tularensis Schu S4 Himar1 transposon library. At 4 h or 24 h
postchallenge, rats were humanely culled and spleen bacterial burden was determined.
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ratio with the WT and used to challenge Fischer 344 rats by the i.v. route. Strains
exhibiting in vitro growth defects were not studied further. Animals were humanely
culled at the humane endpoint, spleens were removed, and the WT and mutant
bacteria were enumerated by culture (Fig. 4B). All deletion strains tested were signiﬁ-
cantly less ﬁt than the WT with the exception of the ΔFTT_0715::Kanr strain, for which
no change in ﬁtness was observed. The reduced ﬁtness of selected mutants, in
competition with the WT, successfully validated the Fischer 344 rat transposon negative
selection screen.
DISCUSSION
The murine model of tularemia has provided signiﬁcant contributions to our un-
derstanding of the molecular pathogenesis of F. tularensis. However, the model is not
without limitation. Mutations have attenuated F. tularensis sufﬁciently for the LVS to be
used for human vaccination (37) but are not sufﬁcient to attenuate the organism in
mice and prevent lethality, indicating that different mechanisms of virulence maybe be
involved for different hosts. The Fischer 344 rat has been used as a model for tularemia
vaccine candidate evaluation due to its reduced sensitivity to pulmonary challenge
with F. tularensis compared to murine models (38, 39). The lower susceptibility of
Fischer 344 rats is described as being closer to that of humans, although similar
susceptibilities of mice and Fischer 344 rats to F. tularensis via the intraperitoneal (i.p.)
route has been noted (38). Fischer 344 rats, like humans, are highly resistant to the LVS
(40), which also provides protection against subsequent challenge with F. tularensis
Schu S4. Given that F. tularensis has a broad host range, to fully understand the genetic
basis for virulence of this pathogen, it may be necessary to study alternative animal
models of infection.
The high insertion frequency of the transposon mutant library described (300,000
unique mutants) provided the opportunity, prior to study in Fischer 344 rats, to identify
genes that are essential in vitro. The analysis identiﬁed 453 genes as essential under the
condition tested. Comparison to data from an F. novicida library of 8,928 mutants (32)
revealed that 339 genes were essential in both species. Although differences in
essentiality prediction between the species potentially reﬂect different metabolisms,
they may also be a consequence of different experimental conditions utilized in the two
studies. To explore genes not previously identiﬁed as essential in Francisella, we
performed BLASTx analysis using the 114 essential genes predicted in F. tularensis Schu
FIG 4 Competitive ﬁtness of F. tularensis Schu S4 mutant strains. The relative ﬁtness of marked mutants was
evaluated in competition with WT F. tularensis Schu S4. Values are presented as means 95% conﬁdence intervals.
Competition under two growth conditions was tested; panel A shows the ﬁtness of individual mutants in vitro in
MMH broth (n 3), and panel B shows the ﬁtness of mutants in Fischer 344 rats (n 5) that were challenged with
the WT and mutant at a 1:1 ratio by the i.v. route. Each datum was analyzed with a one-sample t test comparing
the competitive index to a value of 1.0. A D’Agostino and Pearson omnibus normality test conﬁrmed Gaussian
distribution. *, P  0.05; **, P 0.01; ***, P 0.001.
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S4 but not in F. novicida. Many of these non-DEG essential genes showed homology to
genes from bacteria occupying a marine or environmental niche. Francisella species
have often been associated with aquatic environments (41–43), and the absence of
these novel essential genes identiﬁed in DEG is therefore likely due to the paucity of
essentiality data for organisms occupying this niche.
Our data have identiﬁed a number of essential genes for which no homologue was
identiﬁed in the DEG, of which two conferred a level of functional homology.
FTT_0070c encodes AmpG, a putative muropeptide transporter involved in recycling
peptidoglycan, and shares 38% identity with Escherichia coli AmpG (95% coverage; E
value, 1E93); disruption of ampG in E. coli caused the bacterium to lose up to 40% of
its peptidoglycan per generation (36). Peptidoglycan recycling was also identiﬁed as an
important process in vivo, since ampD (FTT_0162), which encodes a cytoplasmic
amidase (44), was required for ﬁtness within the Fischer 344 rat spleen. A link with
virulence has previously been reported for F. tularensis subsp. holarctica, for which
Brunton et al. (45) observed a reduction in intracellular colonization of ampD mutants
during negative selection in J774 macrophage-like and TC-1 epithelial cells. Given that
the F. tularensis genome has been described as in an advanced state of decay (46), it
is possible that a reduced metabolic repertoire could consequently impose a greater
requirement for peptidoglycan recycling under a number of different growth condi-
tions. Additionally, FTT_0557 shows homology to peroxiredoxins, a thiol-speciﬁc group
of antioxidants. Given the requirement of F. tularensis for cysteine (47, 48), a potential
role for peroxiredoxin-mediated protection from oxidative stress during aerobic growth
is of interest.
In some cases, isogenic mutants have been created in Francisella for a number of
genes we have identiﬁed as essential. Our data predictmglA (macrophage growth locus
A) and ripA (required for intracellular proliferation factor A) to be essential genes for
Schu S4. Yet targetedmglA and ripA deletion strains have been reported for F. tularensis
subsp. holarctica, F. novicida, and F. tularensis subsp. tularensis (with the exception of
mglA in the last) (17, 49–52), suggesting that this gene is dispensable for in vitro growth.
However, growth defects have been reported under certain conditions for both of
these deletion strains (51–53). To our knowledge, mglA deletion has not been reported
for F. tularensis subsp. tularensis. It is therefore plausible that either an absolute
requirement for the mglA exists for F. tularensis subsp. tularensis or a less ﬁt mutant (for
both mglA or ripA) could be lost through competition during outgrowth of our
transposon library. This highlights the need for caution when interpreting competition-
based transposon studies, as the potential exists for selection against mutants with a
growth disadvantage that are not absolutely required for growth under the conditions
of the study.
This Fischer 344 rat screen identiﬁed many genes previously associated with viru-
lence of Francisella in cell lines, animals, and insect models (fully detailed in Table S4)
and contributes to the validation of the sequencing approach used to generate the
data. It was not possible to assess the contribution of the Francisella pathogenicity
island due to sequencing reads mapping to two genomic locations (duplicated 34-kb
region).
To further validate the data generated from the Fischer 344 rat in vivo screen, 8
targeted deletion mutants were produced in F. tularensis Schu S4. Two mutants, F.
tularensis Schu S4 Δlnt::Kanr and ΔFTT_1567c::Kanr mutants, had a reduced competitive
index (CI) in vitro, suggesting a host-independent growth defect when in competition
with WT Schu S4. FTT_1567c contains a ZipA C-terminal domain, as predicted by
Interpro annotation (54, 55). ZipA interacts with FtsZ during cell division, promoting
septum formation (56), and is known to be essential across a number of bacterial
genera (24, 57–62), but due to the narrow conservation of ZipA between bacterial
species, further interrogation is necessary to determine the function of FTT_1567c. The
second mutant exhibiting a defect in growth is the Δlnt::Kanr mutant, in which lnt is
predicted to encode an apolipoprotein N-acyltransferase, an enzyme involved in lipo-
protein maturation (63). Lipoproteins play a diverse role in bacterial pathogens, ranging
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April 2019 Volume 201 Issue 7 e00630-18 jb.asm.org 8
 o
n
 M
arch 29, 2019 by guest
http://jb.asm.org/
D
ow
nloaded from
 
from antibiotic resistance to sporulation and many aspects of bacterial virulence (64).
LoVullo et al. determined that lnt, a gene that is often found to be essential in
Gram-negative bacteria, is not essential for replication of F. tularensis LVS and detected
a minor defect in bacterial physiology (63). Our studies identiﬁed more signiﬁcant
changes to bacterial physiology following deletion of lnt in F. tularensis Schu S4,
primarily a change in cell size during passage in vitro (data not shown) with striking
similarity to the changes observed previously through deletion of a predicted lipopro-
tein, FTT_0831c (65).
This study identiﬁed 34 genes that had not previously been associated with viru-
lence in Francisella. One example is rng, which encodes RNase G. RNases are involved
in RNA processing and decay (66) and have been shown to inﬂuence virulence gene
expression (67, 68). RNase C involvement in F. tularensis Schu S4 virulence was previ-
ously shown in a negative selection screen using human-derived macrophages (69),
and this ﬁnding was consistent with our in vivo Fischer 344 rat data. Inactivation of rng
has been linked to upregulation of the heat shock response genes (70), but its role in
Francisella virulence is unclear. Another potential novel virulence gene identiﬁed is the
FTT_0750 gene, with homology to the elongation factor P–(R)-beta-lysine ligase (EpmB)
gene in Salmonella enterica (98% coverage; E value, 1E101; identity, 45%), which has
been shown to modulate virulence and drug resistance (71). As with many of the genes
identiﬁed in these studies, limited research has been undertaken. This investigation
therefore represents a starting point to stimulate investigations that expand our
knowledge on the pathogenesis of F. tularensis.
Currently, there is no licensed vaccine that can protect against F. tularensis. The LVS
is able to provide protection in humans against aerosol exposure to virulent F. tularensis
(5, 72), but the basis for protection remains unknown. Data generated from this Fischer
344 in vivo negative screen could provide the basis for the rational design of live
vaccine strain candidates. The challenge is to identify candidate mutant strains capable
of sufﬁcient host colonization to induce a robust adaptive immune response but then
unable to disseminate and cause disease. Strains with a greater potential to overat-
tenuate could be identiﬁed by those mutants that have been lost entirely from the
library or present at low levels in the output which may not be sufﬁciently exposed to
the immune system to provide lasting immunity. A number of live attenuated vaccine
candidates have been proposed, such as strains with the clpB (73) and FTT_1103 (74)
genes. These strains have been shown to induce protective immunity and in our study
presented a moderate log2 fold change (1.83 and 1.88, respectively) in the output
(see Table S4 in the supplemental material). Therefore, the potential exists to utilize
transposon-based ﬁtness data to increase the probability of identifying mutant strains
(live vaccine candidates) that are capable of inducing an immune response but are
unable to cause disease.
In conclusion, we have generated a saturated transposon library containing
300,000 unique mutants. In combination with high-throughput next-generation se-
quencing, we have determined gene essentiality of F. tularensis Schu S4 and identiﬁed
genes that are required for ﬁtness within the Fischer 344 rat spleen. We were able to
conﬁrm previously identiﬁed virulence-related genes and identify new ones. Despite
having a diverse host range, Francisella is rarely studied outside the mouse model. Our
studies of gene essentiality and in vivo ﬁtness provide the foundation to further
understand the nutritional requirements and pathogenicity of this highly virulent
organism.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. F. tularensis subsp. tularensis Schu S4 (75) was
used to construct a saturated transposon library. Strains of F. tularensis were grown routinely on modiﬁed
Mueller-Hinton (MMH) agar or broth (76) or Thayer-Martin agar (77). Where required, medium was
supplemented with kanamycin (10 g/ml), chloramphenicol (5 g/ml), or polymyxin B (100 g/ml). All
work with F. tularensis was undertaken with the appropriate laboratory containment conditions. Use of
chloramphenicol and kanamycin resistance cassettes was approved locally by a genetic manipulation
safety committee and approved nationally by the Health and Safety Executive (UK Health and Safety
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Authority). Lists of strains and plasmids (Table S1) and primers (Tables S2 and S3) can be found in the
supplemental material.
Generation of mutant libraries. Mutagenesis of the Francisella tularensis Schu S4 genome was
achieved utilizing a modiﬁed Himar1 transposon (HimarFT) contained within a minimal suicide vehicle
(pHimarH3), for which random, single, and stable insertions within F. tularensis have previously been
demonstrated (28, 78). F. tularensis, grown at 37°C in MMH broth, was rendered electrocompetent by
sequential washing and concentration in 0.5 M sucrose prior to electroporation with 1 g of pHimarH3
at a ﬁeld strength of 15 kV/cm in 0.2-cm-gap cuvettes (79). After recovery in MMH broth for 3 h,
transformants were plated onto MMH agar supplemented with kanamycin. Cell numbers were deter-
mined by serial dilution prior to the collection of transformants directly from the plates. Transformants
were pooled into batches of 40,000 before being combined to create the ﬁnal transposon library of
520,000 mutants.
In vitro essential analysis. A frozen vial of library stock was diluted into 50 ml of MMH broth to an
optical density at 590 nm (OD590) of 0.5 and recovered by overnight incubation at 37°C and 200 rpm,
achieving a ﬁnal OD590 of 3.40. Genomic DNA was isolated with the Puregene yeast/bacterium DNA
puriﬁcation kit (Gentra Systems) according to the manufacturer’s instructions.
In vivo ﬁtness studies in Fischer 344 rats. Female Fischer 344 rats 6 to 7 weeks old (100 g) were
purchased from (Envigo, Indianapolis, IN). The rats had access to food and water with 12-h light/dark
cycles and were acclimatized for 10 days prior to the procedure. Animals were handled under biosafety
level 3 containment conditions within a half-suit isolator, compliant with British standard BS5726. All
procedures within this study were carried out according to the requirements of the United Kingdom
Animal (Scientiﬁc Procedures) Act 1986. A frozen vial of library stock was diluted into 50 ml of MMH broth
to an OD590 of 0.5 and was recovered by overnight incubation at 37°C and 200 rpm, achieving a ﬁnal
OD590 of 3.40. F. tularensis Schu S4 was diluted in phosphate-buffered saline (PBS) to 1 108 CFU per ml,
and 100 l was used to challenge each of six rats via the i.v. route. Humane endpoints were strictly
observed, and animals assessed as incapable of survival were humanely killed by the administration of
1 ml of sodium pentobarbital by the i.p. route. Spleens were removed and homogenized with 2 ml of PBS
using 40 M cell strainers, and for each rat, 100 l of spleen homogenate was spread onto each of eight
MMH agar plates. Bacteria were removed from the agar plates following incubation at 37°C for 48 h and
suspended into 10 ml of PBS. Genomic DNA was recovered using the Puregene Gentra kit according to
the manufacturer’s instructions, with the addition of a proteinase K (100 g/ml) digestion step for 1.5 h
at 55°C following RNase A treatment.
Illumina sequencing. The DNA was separated into approximately 500-bp fragments using a Covaris
machine with settings as follows: time, 110 s; peak incident power (PIP), 105 W; 200 cycles/burst; and 5%
duty factor. The fragments were puriﬁed using a Qiagen PCR puriﬁcation kit according to the manufac-
turer’s instructions. Libraries were prepared using a NEBNext DNA library preparation kit for Illumina,
according to the manufacturer’s instructions: ends were repaired and A-tailed, and then annealed
adapters Ind_Ad-T and Ind_Ad-B were ligated to the free ends. The fragments were then PCR ampliﬁed
in 10 parallel reactions using primers PE_PCR_V3.3 and Ft_1 FC (Table S1B); the reaction mixtures were
made up of 10 l of JumpStart 10 buffer, 6 l of MgCl2, 2 l of 10 mM deoxynucleoside triphosphates
(dNTPs), 0.6 l of 100 M PE_PCR_V3.3 primer, 0.6 l of Ft_1 FC primer, 1 l of JumpStart Taq DNA
polymerase, and 28.8 l of nuclease-free water. The reactions were ampliﬁed at 94°C for 10 min (94°C for
30 s, 65°C for 20 s, and 72°C for 30 s) for 22 cycles and 72°C for 10 min and then held at 12°C. The PCR
products were pooled and quantiﬁed using quantitative PCR (qPCR). They were then size selected on a
2% agarose–1 Tris-borate-EDTA (TBE) gel; agarose blocks were excised corresponding to 350 to 500 bp.
These were treated with a Qiagen MinElute gel extraction kit, and then the DNA fragments were
requantiﬁed both by qPCR and on an Agilent bioanalyzer and sequenced as 100-bp single end reads on
an Illumina Hi-Seq 2500 standard model.
Bioinformatic analysis for essential genes. Adapter sequences and low-quality ends were removed
from the raw sequencing reads using Trimmomatic (80), and reads that had been reduced to below 24 bp
in length were dropped. Processed reads were mapped, insertion sites/read counts were tabulated, and
a prediction of essentiality was determined using the Bio::Tradis pipeline as described previously (30, 31)
(https://github.com/sanger-pathogens/Bio-Tradis). Brieﬂy, reads containing the pHimarH3 transposon
tag were ﬁltered and mapped to the F. tularensis Schu S4 reference genome (EMBL accession number
AJ749949) using SMALT-0.7.2, allowing 0 mismatches. Postprocessing of the mapped reads involved
determination of the gene insertion index (insertion count/gene length) and excluded the ﬁrst 5% and
last 15% of each gene to avoid insertions that may not affect gene function. Gene essentiality was
predicted through ﬁtting gamma distributions to the essential and nonessential peaks of the observed
bimodal distributions. Log2 likelihood ratios were calculated between the two modes providing the
insertion-index threshold and the prediction of gene essentiality. Genes with log2 likelihood ratios of less
than 2 were described as essential, and those with log2 likelihood ratios of greater than 2 were
considered nonessential genes (31).
In vivo ﬁtness analysis by DESeq. Sequence reads were aligned to the reference genome using the
sequence alignment tool BWA (81). The mismatch error limit was set 2. All other parameters used default
values of the tool. After alignment, an in-house script was used to calculate the frequency data for each
gene in each replicate as previously described (82). The “executable C script for annotation” (accessed at
http://ecsb.ex.ac.uk/DEM/index.html) established the frequency of transposon hits across the genome.
The count data were then converted to reads per kilobase of transcript per million mapped reads (RPKM).
The ﬁtness package DESeq (83) analyzed the matrix to predict the differential ﬁtness of individual
mutants. DESeq is a tool for analyzing high-throughput sequence reads data for detecting differentially
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expressed genes with an assumption that the count data follow a binomial distribution. Default values
were used within the DESeq package, and a list detailing the relative abundance of the individual
mutants was generated. The tool generates a list of differentially expressed genes based on the P values
(84).
Generation of marked and unmarked mutants. Marked mutants were generated using a modiﬁed
version of the SacB/oriT suicide plasmid pEDL50 (85) to facilitate the use of the kanamycin gene and its
GroES promoter derived from pHimarH3 as the marker for mutagenesis. The kanamycin resistance gene
on the pEDL50 backbone was replaced with a chloramphenicol resistance gene. Initially, the multiple-
cloning site was removed by restriction digestion with AleI and EcorV and recircularized by ligation. The
resulting plasmid was named pMIRE14 and was generated to remove a second PstI site. The chloram-
phenicol gene from pKK201 (86) was cloned, including a 107-bp upstream region, and was ﬂanked by
5= SpeI and 3= PstI sites. Restriction digestion of the subcloned chloramphenicol gene (Zero Blunt TOPO;
Thermo Fisher) and pMIRE14 with SpeI and PstI followed by ligation allowed the direct replacement of
the kanamycin resistance gene with a chloramphenicol resistance cassette, generating pMIRE15.
To generate marked deletion constructs, ﬂanking regions (750 bp) of the target gene were
ampliﬁed by PCR and ligated into pMIRE15 on either side of a kanamycin resistance gene that had been
ampliﬁed from pHimarH3 (78). The deletion constructs were electroporated into E. coli S17  pir and
mobilized into WT F. tularensis Schu S4 by conjugation as described previously (87). Merodiploids
generated through chromosomal integration of the suicide plasmid were selected on Thayer-Martin agar
containing either chloramphenicol or kanamycin and polymyxin B and incubated at 37°C. Following PCR
veriﬁcation, isolated colonies were spread by diminishing streak onto Thayer-Martin agar supplemented
with 5% (wt/vol) sucrose and 10 g/ml of kanamycin and incubated at 37°C until colonies were evident.
The marked deletion was conﬁrmed by PCR of all mutants and six by whole-genome sequencing.
In vitro competitive index. F. tularensis Schu S4 strains were prepared from sucrose stocks onto
MMH agar and incubated for 24 h at 37°C. Cells were adjusted by OD590 in MMH broth to 5 108 CFU/ml
and incubated for 24 h at 37°C and 220 rpm. Each strain was adjusted by OD590 to 5 108 CFU/ml in
MMH broth and used to prepare a 1:1 ratio of each mutant with WT F. tularensis Schu S4. Growth in
competition was allowed to proceed for 24 h at 37°C. CFU were determined by serial dilution onto both
MMH agar alone and MMH agar with 10 g/ml of kanamycin. CFU values were log10 transformed and
used to calculate the competitive index of WT to marked deletion using the following formula: (mutant
output count/WT output count)/(mutant input count/WT input count).
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